PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 2112564
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 2112564
Real World Evidence Solutions Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2026 - 2032)
The global real world evidence solutions market was valued at USD 2.0 billion in 2025 and is projected to reach USD 5.1 billion by 2032, growing at a CAGR of 14.3% between 2026 and 2032. Growth is being driven by rising clinical trial volumes and a shift toward value-based healthcare, as noncommunicable diseases account for approximately 74% of global deaths annually, according to the World Health Organization, increasing the need for long-term outcome tracking.
Research investment underpins this scale. Higher-education R&D expenditure in health sciences reached USD 38.5 billion in FY 2024, according to the National Center for Science and Engineering Statistics, reflecting sustained investment supporting data generation and clinical evidence development.
RWD and RWE are increasingly used to improve trial protocol design and create synthetic control arms, speeding execution and reducing costs, as life sciences companies adopt cloud technologies for their flexibility and scalability.
Key Insights
Services hold the larger component share, at 75%, as organizations rely on tailored real-world evidence programs rather than raw data analysis. Data Sets post the higher CAGR, at approximately 14.6%; NIH's All of Us Research Program enrolled more than 850,000 participants across all 50 U.S. states as of November 2024.
Drug Development and Approvals is the largest application at 40% share; the Center for Drug Evaluation and Research approved 50 new molecular entities in calendar year 2024, many requiring post-approval monitoring. Market Access Reimbursement and Coverage Decision Making posts the highest CAGR, as payers tie reimbursement to demonstrated real-world value.
Pharmaceutical & Medical Device Companies hold the largest end-user share; member companies of the Pharmaceutical Research and Manufacturers of America have invested over USD 100 billion annually in R&D in recent years. Healthcare Payers post the highest CAGR, at approximately 14.8%; approximately 78% of the 61.0 million Medicare beneficiaries with Part A and Part B coverage were enrolled in managed care arrangements in 2024, according to MedPAC.
North America holds the largest regional share, at 40%, backed by mature healthcare data ecosystems. Real-world evidence appeared in FDA documentation for 23.3%, 27.7%, and 23.7% of drug labeling-expansion approvals in 2022, 2023, and 2024, respectively, according to a PubMed Central analysis.
The U.S. is the largest individual country market; 117 medical devices incorporated real-world evidence in FDA submissions between January 2020 and July 2024, with 74 devices using such evidence to directly support approval.
Asia-Pacific posts the highest regional CAGR, at approximately 15.2%, driven by rising government support and increasing clinical trial volumes. Japan developed platforms such as MID-NET, supported by the Pharmaceuticals and Medical Devices Agency, to promote real-world data use in healthcare decisions.
India launched the Ayushman Bharat Digital Mission to create a nationwide digital health ecosystem, strengthening the foundation for real-world data generation. China's National Medical Products Administration has issued guidelines supporting real-world data use in drug development and regulatory decision-making.
AI and interoperable data infrastructure are a defining trend, as vendors embed natural language processing into data-curation pipelines. 70% of non-federal acute care hospitals engaged in all four domains of interoperable exchange in 2023, up from 46% in 2018, according to the ONC.
Regulatory recognition of real-world evidence remains the biggest driver, as agencies increasingly accept it for label expansions and device clearances. The FDA has authorized over 1,400 AI-enabled medical devices since 1995, generating large volumes of performance data requiring systematic evidence frameworks.
Data privacy and fragmentation risks are the main restraint, as stricter enforcement of data-protection requirements pushes health systems toward conservative data-sharing postures, slowing multi-source dataset expansion.
Clinical trial representation gaps present a clear opportunity. A peer-reviewed study comparing FDA approval-trial demographics against a real-world database covering more than 150 million U.S. patients found none of 17 analyzed trial populations matched expected demographic proportions.
The competitive landscape remains fragmented across large diversified data providers and specialized analytics firms, none holding dominant share given the breadth of capabilities required. Recent activity includes Datavant's July 2025 acquisition of Aetion, combining health data connectivity infrastructure with real-world analytics and causal inference capabilities, and IQVIA's January 2025 partnership with NVIDIA Corporation to develop AI agents automating literature synthesis and clinical data review.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market Size Breakdown, by Component
- 1.4.2. Market Size Breakdown, by Application
- 1.4.3. Market Size Breakdown, by End User
- 1.4.4. Market Size Breakdown, by Region
- 1.4.5. Market Size Breakdown, by Country
- 1.5. Market Data Reporting Unit
- 1.5.1. Revenue
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence Database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Industry Background
- 5.2. Market Dynamics
- 5.2.1. Trends
- 5.2.2. Drivers
- 5.2.3. Restraints/Challenges
- 5.2.4. Emerging Economies and Key Opportunities
- 5.2.5. Impact Analysis of Drivers/Restraints
- 5.3. Sociopolitical Impact
- 5.4. Porter's Five Forces Analysis
- 5.4.1. Bargaining Power of Buyers
- 5.4.2. Bargaining Power of Suppliers
- 5.4.3. Threat of New Entrants
- 5.4.4. Intensity of Rivalry
- 5.4.5. Threat of Substitutes
- 5.5. Lifecycle Analysis
- 5.6. Innovation and Technology Trends
- 5.7. Economic and Regulatory Impact
- 5.8. Market Entry Strategies
Chapter 6. Competitive Landscape
- 6.1. List of Market Players and their Offerings
- 6.2. Market Share of Key Players (2025)
- 6.2.1. Global
- 6.2.2. North America
- 6.2.3. Europe
- 6.2.4. Asia-Pacific
- 6.2.5. Latin America
- 6.2.6. Middle East and Africa
- 6.3. Competitive Benchmarking of Key Players
- 6.4. Product Benchmarking of Key Players
- 6.5. Recent Strategic Developments by Key Players
- 6.6. Company Leadership Matrix
Chapter 7. Global Market
- 7.1. Overview
- 7.2. Market Revenue, by Component (2021-2032)
- 7.3. Market Revenue, by Application (2021-2032)
- 7.4. Market Revenue, by End User (2021-2032)
- 7.5. Market Revenue, by Region (2021-2032)
Chapter 8. North America Market
- 8.1. Overview
- 8.2. Market Revenue, by Component (2021-2032)
- 8.3. Market Revenue, by Application (2021-2032)
- 8.4. Market Revenue, by End User (2021-2032)
- 8.5. Market Revenue, by Country (2021-2032)
Chapter 9. Europe Market
- 9.1. Overview
- 9.2. Market Revenue, by Component (2021-2032)
- 9.3. Market Revenue, by Application (2021-2032)
- 9.4. Market Revenue, by End User (2021-2032)
- 9.5. Market Revenue, by Country (2021-2032)
Chapter 10. Asia-Pacific Market
- 10.1. Overview
- 10.2. Market Revenue, by Component (2021-2032)
- 10.3. Market Revenue, by Application (2021-2032)
- 10.4. Market Revenue, by End User (2021-2032)
- 10.5. Market Revenue, by Country (2021-2032)
Chapter 11. Latin America Market
- 11.1. Overview
- 11.2. Market Revenue, by Component (2021-2032)
- 11.3. Market Revenue, by Application (2021-2032)
- 11.4. Market Revenue, by End User (2021-2032)
- 11.5. Market Revenue, by Country (2021-2032)
Chapter 12. Middle East and Africa Market
- 12.1. Overview
- 12.2. Market Revenue, by Component (2021-2032)
- 12.3. Market Revenue, by Application (2021-2032)
- 12.4. Market Revenue, by End User (2021-2032)
- 12.5. Market Revenue, by Country (2021-2032)
Chapter 13. U.S. Market
- 13.1. Overview
- 13.2. Economic Indicators
- 13.3. Demographics and Population Insights
- 13.4. Growth Drivers
- 13.5. Challenges and Barriers
- 13.6. Competitive Strategies
- 13.7. Emerging Players
- 13.8. Market Size and Forecast
- 13.8.1. Market Revenue, by Component (2021-2032)
- 13.8.2. Market Revenue, by Application (2021-2032)
- 13.8.3. Market Revenue, by End User (2021-2032)
Chapter 14. Canada Market
- 14.1. Overview
- 14.2. Economic Indicators
- 14.3. Demographics and Population Insights
- 14.4. Growth Drivers
- 14.5. Challenges and Barriers
- 14.6. Competitive Strategies
- 14.7. Emerging Players
- 14.8. Market Size and Forecast
- 14.8.1. Market Revenue, by Component (2021-2032)
- 14.8.2. Market Revenue, by Application (2021-2032)
- 14.8.3. Market Revenue, by End User (2021-2032)
Chapter 15. Germany Market
- 15.1. Overview
- 15.2. Economic Indicators
- 15.3. Demographics and Population Insights
- 15.4. Growth Drivers
- 15.5. Challenges and Barriers
- 15.6. Competitive Strategies
- 15.7. Emerging Players
- 15.8. Market Size and Forecast
- 15.8.1. Market Revenue, by Component (2021-2032)
- 15.8.2. Market Revenue, by Application (2021-2032)
- 15.8.3. Market Revenue, by End User (2021-2032)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Economic Indicators
- 16.3. Demographics and Population Insights
- 16.4. Growth Drivers
- 16.5. Challenges and Barriers
- 16.6. Competitive Strategies
- 16.7. Emerging Players
- 16.8. Market Size and Forecast
- 16.8.1. Market Revenue, by Component (2021-2032)
- 16.8.2. Market Revenue, by Application (2021-2032)
- 16.8.3. Market Revenue, by End User (2021-2032)
Chapter 17. France Market
- 17.1. Overview
- 17.2. Economic Indicators
- 17.3. Demographics and Population Insights
- 17.4. Growth Drivers
- 17.5. Challenges and Barriers
- 17.6. Competitive Strategies
- 17.7. Emerging Players
- 17.8. Market Size and Forecast
- 17.8.1. Market Revenue, by Component (2021-2032)
- 17.8.2. Market Revenue, by Application (2021-2032)
- 17.8.3. Market Revenue, by End User (2021-2032)
Chapter 18. Italy Market
- 18.1. Overview
- 18.2. Economic Indicators
- 18.3. Demographics and Population Insights
- 18.4. Growth Drivers
- 18.5. Challenges and Barriers
- 18.6. Competitive Strategies
- 18.7. Emerging Players
- 18.8. Market Size and Forecast
- 18.8.1. Market Revenue, by Component (2021-2032)
- 18.8.2. Market Revenue, by Application (2021-2032)
- 18.8.3. Market Revenue, by End User (2021-2032)
Chapter 19. Spain Market
- 19.1. Overview
- 19.2. Economic Indicators
- 19.3. Demographics and Population Insights
- 19.4. Growth Drivers
- 19.5. Challenges and Barriers
- 19.6. Competitive Strategies
- 19.7. Emerging Players
- 19.8. Market Size and Forecast
- 19.8.1. Market Revenue, by Component (2021-2032)
- 19.8.2. Market Revenue, by Application (2021-2032)
- 19.8.3. Market Revenue, by End User (2021-2032)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Economic Indicators
- 20.3. Demographics and Population Insights
- 20.4. Growth Drivers
- 20.5. Challenges and Barriers
- 20.6. Competitive Strategies
- 20.7. Emerging Players
- 20.8. Market Size and Forecast
- 20.8.1. Market Revenue, by Component (2021-2032)
- 20.8.2. Market Revenue, by Application (2021-2032)
- 20.8.3. Market Revenue, by End User (2021-2032)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Economic Indicators
- 21.3. Demographics and Population Insights
- 21.4. Growth Drivers
- 21.5. Challenges and Barriers
- 21.6. Competitive Strategies
- 21.7. Emerging Players
- 21.8. Market Size and Forecast
- 21.8.1. Market Revenue, by Component (2021-2032)
- 21.8.2. Market Revenue, by Application (2021-2032)
- 21.8.3. Market Revenue, by End User (2021-2032)
Chapter 22. Japan Market
- 22.1. Overview
- 22.2. Economic Indicators
- 22.3. Demographics and Population Insights
- 22.4. Growth Drivers
- 22.5. Challenges and Barriers
- 22.6. Competitive Strategies
- 22.7. Emerging Players
- 22.8. Market Size and Forecast
- 22.8.1. Market Revenue, by Component (2021-2032)
- 22.8.2. Market Revenue, by Application (2021-2032)
- 22.8.3. Market Revenue, by End User (2021-2032)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Economic Indicators
- 23.3. Demographics and Population Insights
- 23.4. Growth Drivers
- 23.5. Challenges and Barriers
- 23.6. Competitive Strategies
- 23.7. Emerging Players
- 23.8. Market Size and Forecast
- 23.8.1. Market Revenue, by Component (2021-2032)
- 23.8.2. Market Revenue, by Application (2021-2032)
- 23.8.3. Market Revenue, by End User (2021-2032)
Chapter 24. Australia Market
- 24.1. Overview
- 24.2. Economic Indicators
- 24.3. Demographics and Population Insights
- 24.4. Growth Drivers
- 24.5. Challenges and Barriers
- 24.6. Competitive Strategies
- 24.7. Emerging Players
- 24.8. Market Size and Forecast
- 24.8.1. Market Revenue, by Component (2021-2032)
- 24.8.2. Market Revenue, by Application (2021-2032)
- 24.8.3. Market Revenue, by End User (2021-2032)
Chapter 25. Brazil Market
- 25.1. Overview
- 25.2. Economic Indicators
- 25.3. Demographics and Population Insights
- 25.4. Growth Drivers
- 25.5. Challenges and Barriers
- 25.6. Competitive Strategies
- 25.7. Emerging Players
- 25.8. Market Size and Forecast
- 25.8.1. Market Revenue, by Component (2021-2032)
- 25.8.2. Market Revenue, by Application (2021-2032)
- 25.8.3. Market Revenue, by End User (2021-2032)
Chapter 26. Mexico Market
- 26.1. Overview
- 26.2. Economic Indicators
- 26.3. Demographics and Population Insights
- 26.4. Growth Drivers
- 26.5. Challenges and Barriers
- 26.6. Competitive Strategies
- 26.7. Emerging Players
- 26.8. Market Size and Forecast
- 26.8.1. Market Revenue, by Component (2021-2032)
- 26.8.2. Market Revenue, by Application (2021-2032)
- 26.8.3. Market Revenue, by End User (2021-2032)
Chapter 27. Saudi Arabia Market
- 27.1. Overview
- 27.2. Economic Indicators
- 27.3. Demographics and Population Insights
- 27.4. Growth Drivers
- 27.5. Challenges and Barriers
- 27.6. Competitive Strategies
- 27.7. Emerging Players
- 27.8. Market Size and Forecast
- 27.8.1. Market Revenue, by Component (2021-2032)
- 27.8.2. Market Revenue, by Application (2021-2032)
- 27.8.3. Market Revenue, by End User (2021-2032)
Chapter 28. South Africa Market
- 28.1. Overview
- 28.2. Economic Indicators
- 28.3. Demographics and Population Insights
- 28.4. Growth Drivers
- 28.5. Challenges and Barriers
- 28.6. Competitive Strategies
- 28.7. Emerging Players
- 28.8. Market Size and Forecast
- 28.8.1. Market Revenue, by Component (2021-2032)
- 28.8.2. Market Revenue, by Application (2021-2032)
- 28.8.3. Market Revenue, by End User (2021-2032)
Chapter 29. U.A.E. Market
- 29.1. Overview
- 29.2. Economic Indicators
- 29.3. Demographics and Population Insights
- 29.4. Growth Drivers
- 29.5. Challenges and Barriers
- 29.6. Competitive Strategies
- 29.7. Emerging Players
- 29.8. Market Size and Forecast
- 29.8.1. Market Revenue, by Component (2021-2032)
- 29.8.2. Market Revenue, by Application (2021-2032)
- 29.8.3. Market Revenue, by End User (2021-2032)
Chapter 30. Company Profiles
Chapter 31. Appendix
- 31.1. Sources and References
- 31.2. Related Reports
